Adolescent and Young Adult Cancer Survivors: Late Effects of Treatment

作者: K. Scott Baker , Andrew A. Toogood , Michael Hawkins , Paul C. Nathan

DOI: 10.1007/978-3-319-33679-4_28

关键词:

摘要: The incidence of cancer in YAs has steadily increased over the past 25 years, and remains a leading cause non-accidental death this age group. Unlike older patients, AYAs tolerate acute side effects therapy relatively well. However, therapies can produce complications that may not become apparent until years later, hence term “late effect” for late-occurring or chronic outcomes – either physical psychological persist develop beyond 5 from diagnosis cancer. Approximately two out every three survivors will experience at least one late effect, about four effect is severe life threatening. These involve all organ systems. resulting include cardiopulmonary compromise, endocrine dysfunction, renal impairment, gastrointestinal musculoskeletal sequelae, subsequent malignancies. are related only to specific employed but also be determined by individual host characteristics. This chapter review known occurring during adolescence young adulthood discuss relationship between these therapeutic modalities (surgery, radiation, chemotherapy) combined-modality regimens, including those used blood marrow transplantation. Screening recommendations, options providing survivorship care, future research opportunities need explored discussed.

参考文章(160)
F. E. van Leeuwen, W. J. Klokman, M. Stovall, E. C. Dahler, M. B. van't Veer, E. M. Noordijk, M. A. Crommelin, B. M. P. Aleman, A. Broeks, M. Gospodarowicz, L. B. Travis, N. S. Russell, Roles of Radiation Dose, Chemotherapy, and Hormonal Factors in Breast Cancer Following Hodgkin’s Disease Journal of the National Cancer Institute. ,vol. 95, pp. 971- 980 ,(2003) , 10.1093/JNCI/95.13.971
Brennan, Rahim, Mackie, Eden, Shalet, Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood Clinical Endocrinology. ,vol. 48, pp. 777- 783 ,(1998) , 10.1046/J.1365-2265.1998.00438.X
Marie L. De Bruin, Judith Sparidans, Mars B. van't Veer, Evert M. Noordijk, Marieke W.J. Louwman, Josée M. Zijlstra, Hendrik van den Berg, Nicola S. Russell, Annegien Broeks, Margreet H.A. Baaijens, Berthe M.P. Aleman, Flora E. van Leeuwen, Breast Cancer Risk in Female Survivors of Hodgkin's Lymphoma: Lower Risk After Smaller Radiation Volumes Journal of Clinical Oncology. ,vol. 27, pp. 4239- 4246 ,(2009) , 10.1200/JCO.2008.19.9174
G. Gatta, R. Capocaccia, R. De Angelis, C. Stiller, J.W. Coebergh, Cancer survival in European adolescents and young adults. European Journal of Cancer. ,vol. 39, pp. 2600- 2610 ,(2003) , 10.1016/J.EJCA.2003.09.004
Daniela Cardinale, Alessandro Colombo, Rosalba Torrisi, Maria T. Sandri, Maurizio Civelli, Michela Salvatici, Giuseppina Lamantia, Nicola Colombo, Sarah Cortinovis, Maria A. Dessanai, Franco Nolè, Fabrizio Veglia, Carlo M. Cipolla, Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation Journal of Clinical Oncology. ,vol. 28, pp. 3910- 3916 ,(2010) , 10.1200/JCO.2009.27.3615
Chaya S Moskowitz, Joanne F Chou, Suzanne L Wolden, Jonine L Bernstein, Jyoti Malhotra, Danielle Novetsky Friedman, Nidha Z Mubdi, Wendy M Leisenring, Marilyn Stovall, Sue Hammond, Susan A Smith, Tara O Henderson, John D Boice, Melissa M Hudson, Lisa R Diller, Smita Bhatia, Lisa B Kenney, Joseph P Neglia, Colin B Begg, Leslie L Robison, Kevin C Oeffinger, None, Breast Cancer After Chest Radiation Therapy for Childhood Cancer Journal of Clinical Oncology. ,vol. 32, pp. 2217- 2223 ,(2014) , 10.1200/JCO.2013.54.4601
Stephen M. Shalet, Elena Shavrikova, Morris Cromer, Christopher J. Child, Eberhard Keller, Jirina Zapletalová, Thomas Moshang, Werner F. Blum, John J. Chipman, Charmian A. Quigley, Andrea F. Attanasio, Effect of Growth Hormone (GH) Treatment on Bone in Postpubertal GH-Deficient Patients: A 2-Year Randomized, Controlled, Dose-Ranging Study The Journal of Clinical Endocrinology and Metabolism. ,vol. 88, pp. 4124- 4129 ,(2003) , 10.1210/JC.2003-030126
L. C.M. Kremer, E. C. van Dalen, M. Offringa, J. Ottenkamp, P. A. Voûte, Anthracycline-Induced Clinical Heart Failure in a Cohort of 607 Children: Long-Term Follow-Up Study Journal of Clinical Oncology. ,vol. 19, pp. 191- 196 ,(2001) , 10.1200/JCO.2001.19.1.191
J.M. O’Sullivan, R.A. Huddart, A.R. Norman, J. Nicholls, D.P. Dearnaley, A. Horwich, Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours Annals of Oncology. ,vol. 14, pp. 91- 96 ,(2003) , 10.1093/ANNONC/MDG020
K. Scott Baker, Eric J. Chow, Pamela J. Goodman, Wendy M. Leisenring, Andrew C. Dietz, Joanna L. Perkins, Lisa Chow, Alan Sinaiko, Antoinette Moran, Anna Petryk, Julia Steinberger, IMPACT OF TREATMENT EXPOSURES ON CARDIOVASCULAR RISK AND INSULIN RESISTANCE IN CHILDHOOD CANCER SURVIVORS Cancer Epidemiology, Biomarkers & Prevention. ,vol. 22, pp. 1954- 1963 ,(2013) , 10.1158/1055-9965.EPI-13-0610